Xin Zhao
- Cancer Research top 5%
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 8
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 10%
- Circular RNAs in diseases 9
- Genetics top 10%
-
- Cancer Immunotherapy and Biomarkers 4
-
- Aortic Disease and Treatment Approaches 5
-
- Pain Mechanisms and Treatments 5
-
- Prenatal Screening and Diagnostics 4
- Co-authors
- Yuzhou LiuKejing WangHongquan GuanTeresa DavoliJoy J. BianchiYou ZhouYao WangXianglan Sun
- Journals
- Proceedings of the National Academy of Sciences (2 papers)PLoS ONE (1 paper)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xin Zhao
95 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 138
- Cancer Research 497
- Molecular Biology 880
- Cardiology and Cardiovascular Medicine 237
- Genetics 96
- Oncology 208
Countries citing papers authored by Xin Zhao
This map shows the geographic impact of Xin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Zhao more than expected).
Fields of papers citing papers by Xin Zhao
This network shows the impact of papers produced by Xin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Zhao. The network helps show where Xin Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 33 | |
| 12 | 2020 | 4 | |
| 13 | 2019 | 3 | |
| 14 | 2016 | 106 | |
| 15 | 2015 | 20 | |
| 16 | 2015 | 11 | |
| 17 | 2015 | 3 | |
| 18 | 2013 | 68 | |
| 19 | Identification a novel MYOC gene mutation in a Chinese family with juvenile-onset open angle glaucoma. | 2010 | 14 |
| 20 | 2000 | 8 |
About Xin Zhao
Xin Zhao is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 103 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (8 papers), Cancer Genomics and Diagnostics (5 papers), Aortic Disease and Treatment Approaches (5 papers), Pain Mechanisms and Treatments (5 papers), Prenatal Screening and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (497 citations), Molecular Biology (880 citations) and Cardiology and Cardiovascular Medicine (237 citations). Xin Zhao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuzhou Liu, Kejing Wang, Hongquan Guan, Teresa Davoli, Joy J. Bianchi, You Zhou, Yao Wang, Xianglan Sun, Jingjing Li and Jingyao Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.